Cargando…
The Botanical Drug PBI-05204, a Supercritical CO(2) Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties
Glioblastoma multiform (GBM) is the most common primary glial tumor resulting in very low patient survival despite current extensive therapeutic efforts. Emerging evidence suggests that more effective treatments are required to overcome tumor heterogeneity, drug resistance and a complex tumor-suppor...
Autores principales: | Colapietro, Alessandro, Yang, Peiying, Rossetti, Alessandra, Mancini, Andrea, Vitale, Flora, Martellucci, Stefano, Conway, Tara L., Chakraborty, Sharmistha, Marampon, Francesco, Mattei, Vincenzo, Gravina, Giovanni Luca, Biordi, Assunta Leda, Wei, Daoyan, Newman, Robert A., Festuccia, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516200/ https://www.ncbi.nlm.nih.gov/pubmed/33013390 http://dx.doi.org/10.3389/fphar.2020.552428 |
Ejemplares similares
-
The Botanical Drug PBI-05204, a Supercritical CO(2) Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human Glioblastoma
por: Colapietro, Alessandro, et al.
Publicado: (2022) -
The botanical drug PBI-05204, a supercritical CO(2) extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo
por: Vaccaro, Sara, et al.
Publicado: (2022) -
Erratum: The Botanical Drug PBI-05204, a Supercritical CO(2) Extract of Nerium Oleander, is Synergistic With Radiotherapy in Models of Human Glioblastoma
por: Frontiers Production Office,
Publicado: (2022) -
PBI-05204, a supercritical CO(2) extract of Nerium oleander, inhibits growth of human pancreatic cancer via targeting the PI3K/mTOR pathway
por: Pan, Yong, et al.
Publicado: (2014) -
Renal Lesions in Horses with Oleander (Nerium oleander) Poisoning
por: Sykes, Chelsea A., et al.
Publicado: (2022)